Rutgers Cancer Institute seeks a nationally recognized clinical researcher focused in lymphoid, plasma cell, or myeloid malignancies, with proven leadership experience and a distinguished record of original clinical research, exceptional clinical and educational skills, and a commitment to the Institute's mission, to serve as the Chief of Hematologic Malignancies at Rutgers Cancer Institute and Rutgers Robert Wood Johnson Medical School. The Chief will have oversight of the clinical practice, clinical research activities, and faculty mentorship and development, with the opportunity to build on a solid foundation of excellence, including preeminent research, outstanding clinical services, and prominent educational programs. The Chief will have the unique opportunity to develop the hematologic malignancies clinical program in alignment with Rutgers Cancer Institute of New Jersey and the RWJBarnabas Health partner strategy.

The Chief will join the leadership team of the Division of Blood Disorders to lead a well-established clinical and research Section of Hematologic Malignancies with a portfolio of first in human to phase 3 clinical trials (industry, cooperative group, and investigator-initiated trials). The Chief will be key in shaping the growing Section, including leading currently active and forecasted clinical and research faculty recruitment.  

Rutgers Cancer Institute of New Jersey, the state’s only NCI-designated Comprehensive Cancer Center located in New Brunswick, NJ, and RWJBarnabas Health, the state’s largest health care delivery system, partner to deliver high-quality and sophisticated oncology care to patients close to home. This integrated cancer care model combines the strength of both entities, offering access to the most advanced diagnostic and treatment options for adult and pediatric cancer patients, including clinical trials, immunotherapy, proton therapy, precision medicine, CAR T-cell therapy and cardio-oncology. Unique opportunities exist for collaborations between clinical and research programs, including clinical trials research, cancer chemoprevention, clinical and basic pharmacology, and Phase 1 clinical trials. Visit: www.cinj.org.

RWJBarnabas Health is New Jersey's largest integrated healthcare delivery system, a $6 billion health system including 11 hospitals providing treatment and services to more than three million patients each year. RWJBarnabas Health brings the best of academic medicine, research, and teaching, and community partners together to create healthier communities. Through a long-standing relationship with Rutgers University and its two medical schools, the system is able to access the latest in medical research and treatment technologies. RWJBarnabas Health works with Rutgers Robert Wood Johnson Medical Schools to train and educate more than 1,650 medical residents and interns throughout its hospitals each year.

Must have MD/DO/MBBS, be ABIM certified, board certified/eligible in hematology or medical oncology, have completed a 3-year fellowship, and either have or be eligible for a NJ Medical License. Leadership experience in an academic medical center is strongly preferred. Academic appointment will be in the Department of Medicine, Rutgers Robert Wood Johnson Medical School. Academic rank (Associate/Professor) will be commensurate with experience. Attractive recruitment package exists.

Rutgers Cancer Institute is committed to retaining, recruiting, and developing outstanding faculty, staff, and students, including those traditionally underrepresented in medicine in faculty, staff, and student bodies. It aspires to be an agent of progress in advancing equality and justice while improving healthcare access and reducing healthcare disparities. Faculty will have the exciting opportunity to be involved in teaching activities for medical students and residents as well as targeted lectures in their area of expertise.

For questions on this position or to learn more about our available positions, please contact the Rutgers Cancer Institute Faculty Recruitment Office at: facultyaffairs@cinj.rutgers.edu. Please contact us to schedule a meeting with our Blood Disorders leadership team at the 2022 ASH meeting!

To apply, visit: https://jobs.rutgers.edu/postings/185017